Recently, we put out a call for COVID-19 projects, and the response for China partnerships in this matter has been overwhelming. In just two weeks, we received nearly 300 requests from more than 20 countries. After a rigorous screening process by Chinese...
Paul Zhang is currently a Partner at BlueStar Bioadviors LLC., having been a Partner at Easton Associates LLC, a Managing Director at Navigant (which acquired Easton) and ClearView Healthcare Partners. He is now an accomplished life science consultant, but his career...
San Francisco, CA, USA (January 12, 2020)-Hosted by MyBioGate and CUBIO Innovation Center, China Focus @ San Francisco 2020 conference was held successfully at the Grand Hyatt Hotel in San Francisco, USA. As the largest China-themed partnering conference during JPM...
We are pleased to announce that the following splendid companies will make presentations at China Focus@ San Francisco! Bayer (China): a leading multinational pharma company in China with leadership in China’s key therapeutic areas such as Diabetes,...
Atomwise Inc., invented the first deep learning AI technology for structure-based small molecule drug discovery, will partner with Hansoh Pharmaceutical Group Company Limited, a leading biopharmaceutical company in China, to design and discover potential drug...
A license agreement has been reached between Alligator Bioscience with Biotheus Inc., a Chinese company based in Guangdong, China. Under the license agreement, Alligator has granted Biotheus rights in Greater China (including Republic of China,...
March, 2019, Ambrx, Inc. and BeiGene, Ltd announced a global research and development collaboration. BeiGene is a global, commercial-stage, research-based biotechnology company focused on immuno-oncology cancer therapeutics. With a team of over 2,200 employees in...
JP Morgan Week is fast approaching, that annual time when one of the world’s leading investment and banking firms looks to the future. Business professionals from almost every industry and sector attend conferences during this time to learn more about what’s to come...
How do you feel about bio-medical conferences, conventions, and health summits? Do you love attending? Do you navigate the floor with ease or are you not sure where to go, or perhaps see it as a significant expense? Once you sort through the number of conferences...
China pharma sector, the second largest in the world, continues to grow rapidly on a CAGR of 10%, which will reach ~$393 Billion in 2025. Key regulatory changes • China Joined ICH in 2017: fast drug approval and match the global standards • NRDL (National...
Featuring 1-on-1 meeting opportunities, China Focus@San Francisco will take place on Jan 12, 2020, in San Francisco. Almost 200 business leaders and enthusiastic investors are ready to schedule personal meetings with you! With our instant online scheduling platform,...
Introduction J.P. Morgan 38th Annual Healthcare Conference (JPM 2020) will take place 13-16 January 2020 in San Francisco, CA, USA. The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry,...
In 2018, Chinese companies made more than 150 cross-border life sciences licensing deals, with the average upfront payment of ~$10 Million, having reached a record high. Over 40% of early- and late-stage assets entered China market through licensing deals. In this...
Forbes released its annual Midas List of the best dealmakers in venture capital and the Chinese were outstanding in the 2019 rankings. Selected Deals in 2019 Apic Bio completed a $40 million Series A financing led by Morningside Venture Cullgen of San Diego Raises $16...
Application for company presentation at China Focus@ San Francisco is open now! Pitch your company directly to – Renowned investors – China’s Leading Companies – Global Pharma Companies Much more value-added in addition to the 10 minutes...
China’s domestic pharmaceutical consumption has increased dramatically in the past several years. By 2020, China is expected to grow its pharmaceutical market volume to $220 billion USD, becoming the second-largest market after the United States, as reported by...
MyBioGate Global Healthcare Innovation Competition is a cross-border platform that connects global innovations in healthcare with the growing market, capital, and resources in China. We aim to help companies from overseas find out and connect with trustworthy Chinese...
China Focus@San Francisco registration officially launched! Register now to be a part of the busiest week in healthcare. China Focus@San Francisco is a cross-border partnering conference for opportunities in China’s healthcare and life sciences industry. More...
Join us at the new module of China Focus@ San Francisco: Medical Device Challenge, a medical device focused partnering and presenting meeting.Apply now and win the complimentary general admission. What is Medical Device Challenge? What can I get? ...
Recent Comments